---
title: "吉利德HIV疫苗在晚期试验中显示出100%的有效性"
description: "吉利德HIV疫苗在晚期试验中显示出100%的有效性"
image: https://image.informedainews.com/2024/06/21/Ar-NIz-1718958072-0.jpg
---


:::info

“智闻AI“ 是由人工智能编撰的刊物集合，确保您只获得最有价值的信息，旨在助您消除信息差，突破信息茧房的局限。  [了解更多 >>](/)

:::

# 吉利德HIV疫苗在晚期试验中显示出100%的有效性

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">
<img
  src="https://image.informedainews.com/2024/06/21/Ar-NIz-1718958072-0.jpg"
  alt="Gilead's HIV Vaccine Demonstrates 100% Efficacy in Late-Stage Trial"
/>



吉利德公司的HIV疫苗，每年仅需注射两次，在后期试验中证明100%有效。在2000名女性中，接种疫苗后无一感染HIV。数据监测委员会现建议继续盲态试验并提供治疗给所有试验参与者。这一突破可能彻底改变HIV预防（PrEP）并增强吉利德的市场地位。股价上涨了7%。吉利德HIV临床开发副总裁贾里德·贝滕强调，需要多样化的PrEP选项以适应个人需求。
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 5    | Content provides factual information about the trial results without evident bias.    |
	| Social Impact | 6     | Significant impact on public health and HIV prevention strategies.    |
	| Credibility    | 5    | Based on late-stage trial data from a reputable pharmaceutical company.    |
	| Potential    | 6    | High potential to revolutionize HIV prevention and treatment.    |
	| Practicality    | 5    | Practical application in HIV prevention with just two injections per year.    |
	| Entertainment Value    | 3    | Some interest due to medical breakthrough, but primarily informative rather than entertaining.    |
</TabItem>
</Tabs>

[Full article>>](https://www.cnbeta.com.tw/articles/tech/1435515.htm)
